CVKD,Cadrenal Therapeutics, Inc. | Healthcare

Healthcare

CVKD

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Cadrenal Therapeutics, Inc.CVKD

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company.

The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation.

The company was incorporated in 2022 and is headquartered in Ponte Vedra, Florida.

Latest News >

MarketBuzz Podcast With Sonia Shenoy: Sensex, Nifty likely to open flat amid mixed global cues

Aug 30, 2021

The Indian market is likely to open flat Tuesday as the trend on SGX Nifty indicates a flat to negative start for the broader index in India. The Nifty futures were trading 39.50 points or 0.23 percent lower at the 16,925.00 level on the Singaporean Exchange at 8:20 am.

Trade Setup for Aug 31: Is Nifty50 hitting 17,000 inevitable now? Check key market cues before Tuesday’s session

Aug 30, 2021

Analysts say the Nifty50 index looks set to rise further going forward. Here's how the August 31 session is poised to start.

10 things you need to know before the opening bell on August 31

Aug 30, 2021

Indian shares are likely to open lower on Tuesday following a mixed trend in Asian peers. The trends on SGX Nifty also indicate a flat to a lower start for the broader index in India. The Nifty futures were trading 24.70 points or 0.15 percent lower at the 16,927.00 level on the Singaporean Exchange at 8:05 am.

Here’s a look at buzzing stocks for trade on August 31

Aug 30, 2021

The Indian market is likely to open flat Tuesday as the trend on SGX Nifty indicates a flat to lower start for the broader index in India amid mixed global cues.